 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
2-26-2024
Insider Buy |
Harry M. Jansen Kraemer Jr.
Director |
$31.55
CAGR »
|
$1,104,351.50
35,000 shares |
10-30-2023
Insider Buy |
Elizabeth D. Bierbower
Director |
$26.37
CAGR »
|
$79,110.00
3,000 shares |
8-17-2023
Insider Buy |
R. Carter Pate
Director |
$34.32
CAGR »
|
$50,278.80
1,465 shares |
8-14-2023
Insider Buy |
Collin Smyser
GC & Corporate Secretary |
$34.69
CAGR »
|
$86,725.00
2,500 shares |
8-11-2023
Insider Buy |
Harry M. Jansen Kraemer Jr.
Director |
$34.63
CAGR »
|
$1,904,518.00
55,000 shares |
8-17-2021
Insider Buy |
Harry M. Jansen Kraemer Jr.
Director |
$21.47
CAGR »
|
$1,073,308.22
50,000 shares |
5-19-2021
Insider Buy |
Harry M. Jansen Kraemer Jr.
Director |
$17.59
CAGR »
|
$703,656.00
40,000 shares |
5-11-2021
Insider Buy |
Michael H. Shapiro
CHIEF FINANCIAL OFFICER |
$16.33
CAGR »
|
$40,825.00
2,500 shares |
5-10-2021
Insider Buy |
R. Carter Pate
Director |
$16.74
CAGR »
|
$14,313.81
855 shares |
5-11-2021
Insider Buy |
John Charles Rademacher
CHIEF EXECUTIVE OFFICER |
$16.42
CAGR »
|
$164,236.00
10,000 shares |
5-11-2020
Insider Buy |
Alan Troy Nielsen
Director |
$12.55
CAGR »
|
$25,090.20
2,000 shares |
Also See: Institutional Holders of OPCH
Also See: SEC filings
Below we present the annualized performance delivered by Option Care Health stock since 2-26-2024 (the date of the most recent
insider purchase). The performance of the investment from the time Option Care Health insider buying occurred is the ultimate
test of whether insiders were right about OPCH being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/27/2024 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$32.76 |
|
| End price/share: |
$29.61 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-9.62% |
|
| Annualized Gain: |
-60.51% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$9,038.00 |
|
| Years: |
0.16 |
|
Option Care Health Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Option Care Health insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding OPCH
|
|
Free OPCH Email Alerts:
